Medtronic Thailand
Medtronic Thailand is the Thai subsidiary of Medtronic plc (NYSE: MDT, Ireland HQ). ~9% of Thai medical-device market value — the largest MNC subsidiary by market share excluding imaging leaders. Portfolio: cardiac (pacemakers, defibrillators, heart valves), surgical (Covidien stapling, energy, wound closure), diabetes (insulin pumps, CGM), neuroscience (deep brain stim, spinal), ENT, respiratory. Dominant in Thai pacemaker, catheter, insulin-pump supply.
Snapshot
Headline numbers a buyer checks first.
Thai market share
~9% by value
FY2024
Parent
Medtronic plc (NYSE: MDT)
Subsidiary since 1996
Portfolio
Surgical, cardiac, diabetes, neuro
FY2024
Status
Private Thai subsidiary
Ongoing
What this subsidiary actually does
Medtronic Thailand imports, distributes Medtronic plc cardiac, surgical, diabetes, neuroscience devices. Cardiac franchise: pacemakers, ICDs, cardiac-resynchronisation therapy, heart valves (Evolut TAVR), catheter ablation. Surgical: Covidien stapling, energy (LigaSure), wound closure. Diabetes: 780G insulin pump, CGM. Neuroscience: deep brain stimulation, spinal cord stimulation. Near-monopoly in Thai pacemaker, ICD supply; leading position in diabetes pumps, spinal devices.[]
Competitive position: #1 MNC-subsidiary by Thai market share. Cardiac, diabetes, neuroscience specialty-device leadership. Competes against J&J MedTech, Abbott in surgical, cardiovascular; Boston Scientific, Abbott in cardiac; Stryker in orthopedic.[, ]
Product portfolio segments
Cardiac devices
Pacemakers, ICD, and TAVR
Near-monopoly supply of cardiac implantable devices in Thailand: pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronisation therapy devices. Evolut TAVR (transcatheter aortic valve) is expanding in private hospitals. NHSO high-cost-equipment programme funds public-hospital adoption.
Surgical
Covidien stapling and energy devices
Covidien-branded advanced surgical stapling, LigaSure energy, and wound-closure devices are deployed across Thai operating theatres in private and public hospitals. Post-Covidien integration, Medtronic holds the leading position in Thai advanced surgical devices.
Diabetes management
Insulin pumps and CGM
780G insulin pump and continuous glucose monitoring (CGM) systems are the primary diabetes-device products. Thailand's growing diabetes prevalence (estimated 5M diabetics) drives demand from endocrinology and internal-medicine departments.
Neuroscience
DBS, spinal, and ENT
Deep brain stimulation (DBS) for Parkinson's and tremor, spinal cord stimulation for chronic pain, and ENT devices. Smaller revenue contribution than cardiac and surgical but high-margin specialty applications in neurology centres.
Thai medical-device MNC subsidiaries — peer comparison
Major MNC medical-device subsidiaries by Thai market share, FY2024 estimates
Parent listing
NYSE:MDT
Thai mkt share (est.)
~9%
Key specialty
Cardiac, surgical, diabetes, neuro
NHSO high-cost access
Pacemakers, ICD covered
Parent listing
ETR:SHL
Thai mkt share (est.)
Key specialty
CT, MRI, IVD, laboratory
NHSO high-cost access
Imaging equipment tenders
Parent listing
NASDAQ:GEHC
Thai mkt share (est.)
Key specialty
CT, ultrasound, monitoring
NHSO high-cost access
Imaging equipment tenders
Parent listing
NYSE:ABT
Thai mkt share (est.)
~6%
Key specialty
IVD, CGM, cardiovascular
NHSO high-cost access
IVD diagnostics, cardio
J&J MedTech Thailand
Parent listing
NYSE:JNJ
Thai mkt share (est.)
~7%
Key specialty
Surgical, orthopedic, wound care
NHSO high-cost access
Orthopedic joint-replacement
| Company | Parent listing | Thai mkt share (est.) | Key specialty | NHSO high-cost access |
|---|---|---|---|---|
| Medtronic Thailand | NYSE:MDT | ~9% | Cardiac, surgical, diabetes, neuro | Pacemakers, ICD covered |
| Siemens Healthineers Thailand | ETR:SHL | ~12% | CT, MRI, IVD, laboratory | Imaging equipment tenders |
| GE HealthCare Thailand | NASDAQ:GEHC | ~8% | CT, ultrasound, monitoring | Imaging equipment tenders |
| Abbott Thailand | NYSE:ABT | ~6% | IVD, CGM, cardiovascular | IVD diagnostics, cardio |
| J&J MedTech Thailand | NYSE:JNJ | ~7% | Surgical, orthopedic, wound care | Orthopedic joint-replacement |
Watchpoints 2025-2026
NHSO
High-cost medical-equipment coverage
NHSO's high-cost-equipment programme (pacemakers, ICDs, hip implants) is the primary volume driver for Medtronic's cardiac and orthopedic franchise in public hospitals. Budget sufficiency and NHSO unit-pricing negotiations directly affect volumes.
Growth
CGM and insulin-pump adoption
Thailand's 5 million diabetics represent a large underpenetrated CGM and insulin-pump market. Adoption depends on private-insurance coverage expansion, NHSO benefit extension, and endocrinologist prescription patterns.
Competition
Abbott and Boston Scientific cardiac rivalry
Abbott's cardiovascular portfolio (Confirm Rx, FreeStyle Libre CGM) and Boston Scientific's cardiac electrophysiology line are the primary competitive threats to Medtronic's cardiac franchise in Thailand's private-hospital market.
Related Market profiles
Peers, parents, partners, agencies, and other Medical Devices actors.
Competitor
Johnson & Johnson MedTech Thailand
Direct surgical, orthopedic competitor.
Open Market profile →
Competitor
Abbott Thailand
Diabetes, cardiovascular overlap.
Open Market profile →
Sector peer
Becton Dickinson Thailand (BD Thailand)
Thai subsidiary of Becton Dickinson (NYSE: BDX); distributes and markets BD's medical devices, diagnostics, and life-science products across the Thai healthcare market.
Open Market profile →
Sector peer
Bionova Thailand
Thai distributor and representative of in-vitro diagnostic and medical-device products serving hospitals and clinical laboratories across Thailand.
Open Market profile →
Sources + data provenance
Every filing, filing-adjacent register, or trusted industry source cited in this profile.
Medtronic Thailand — Subsidiary Disclosures
NHSO — High-Cost Equipment, Specialty Device Programme
| Source | Publisher | Grade | As of |
|---|---|---|---|
| Medtronic Thailand — Subsidiary Disclosures | Medtronic Thailand | Supporting | 2025-12-31 |
| NHSO — High-Cost Equipment, Specialty Device Programme | National Health Security Office | Primary | 2026-03-31 |
Reports featuring this profile
Thailand CGM & Wearable Health Tracker 2027 Market Intelligence
Medtronic Thailand MiniMed 780G hybrid closed-loop pump plus Guardian Sensor 4 and Guardian Connect CGM portfolio; intensive Type-1 clinical anchor with NHSO Q3 2026 Universal Coverage reimbursement u
Open report →
Sits alongside 1 other Atlas profileThailand Medical Devices Market Intelligence
Ireland-HQ global MNC surgical, cardiac, diabetes, neurology leader; ~9% Thai medical-device market share.
Open report →
Sits alongside 7 other Atlas profiles